What is Myelodysplastic Syndromes?
FINAL CONTENT TO COME (this section)
Myelodysplastic syndromes (MDS) represent a group of myeloid (bone marrow) stem cell disorders that gradually affect the ability of a person’s bone marrow to produce normal red blood cells, white blood cells, and platelets.
Bone marrow is a semi-liquid tissue that is inside many bones such as the backbones, shoulder blades, ribs, pelvis, and stomach. The hematopoietic (blood-forming) stem cells in the bone marrow are responsible for producing and forming new blood cells. Erythrocytes, or mature red blood cells, help transport oxygen. White blood cells, (leukocytes) are one of the most critical elements of the circulatory system because they help protect the body against infections caused by foreign microorganisms such as bacteria and viruses. Platelets are the smallest cells in the blood and are formed in the red bone marrow. They help control bleeding and bruising.
About the Medifocus Guidebook on Myelodysplastic Syndromes
If you or a loved one has been diagnosed with Myelodysplastic Syndromes, it's critical to learn everything you possibly can about this condition so that you can make informed decisions about your treatment. That's why we created the Medifocus Guidebook on Myelodysplastic Syndromes, a comprehensive 189 page guide to symptons, treatments, research and support. Available as either a soft-cover book or in PDF format, this unique guidebook answers many of your most important questions about Myelodysplastic Syndromes including:
- What are the causes and risk factors for Myelodysplastic Syndromes?
- What are the signs and symptoms?
- Which medical tests and procedures are necessary to establish and confirm the diagnosis?
- What are the goals of treatment?
- What are the standard treatments?
- What are the treatment options?
- What impact does this condition have on quality of life?
- Are there any new promising treatments currently under development?
- Where can you find doctors, hospitals, and medical centers with specialized expertise in managing patients with Myelodysplastic Syndromes?